Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects
Public ClinicalTrials.gov record NCT03289780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to collect information about how a doctor uses the results of the VeriStrat® blood test to guide treatment for non-small cell lung cancer (NSCLC) patients. Understanding how VeriStrat test results influence doctors' decisions and patients' outcomes may help doctors to better treat NSCLC in the future. This study will also look to establish whether new investigational tests can help better predict the effectiveness of certain medications for certain patients. These new investigational tests are only for research purposes at this time.
Study identification
- NCT ID
- NCT03289780
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 5,006 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 4, 2016 (Actual)
- Primary completion
- Dec 2025 (Estimated)
- Completion
- Dec 2025 (Estimated)
- Last update posted
- Sep 19, 2025
2016 – 2025
United States locations
- U.S. sites
- 42
- U.S. states
- 23
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oncology Specialties, PC; Clearview Cancer Institute | Huntsville | Alabama | 35805 | — |
| Lewis & Faye Manderson Cancer Center at DCH Regional Medical Center | Tuscaloosa | Alabama | 35401 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| St. Bernards Cancer Center Hematology / Oncology | Jonesboro | Arkansas | 72401 | — |
| Valley Medical Oncology Consultants | Pleasanton | California | 94588 | — |
| Eastern Connecticut Hematology and Oncology Associates | Norwich | Connecticut | 06360 | — |
| Boca Raton Regional Hospital -Lynn Cancer Institute | Boca Raton | Florida | 33486 | — |
| Lake City Cancer Care, LLC | Lake City | Florida | 32024 | — |
| South Eastern Regional Medical Center | Newnan | Georgia | 30265 | — |
| Summit Cancer Care | Savannah | Georgia | 31405 | — |
| South Georgia Medical Center | Valdosta | Georgia | 31602 | — |
| Edward-Elmhurst Healthcare | Naperville | Illinois | 60540 | — |
| Illinois Cancer Care | Peoria | Illinois | 61615 | — |
| Franciscan St. Francis Health | Indianapolis | Indiana | 46237 | — |
| Franciscan Health Woodland Cancer Center | Michigan City | Indiana | 46360 | — |
| Ponchartrain Cancer Center | Covington | Louisiana | 70433 | — |
| Christus Health | Shreveport | Louisiana | 71105 | — |
| North Mississippi Medical Center - Hematology and Oncology Clinic | Tupelo | Mississippi | 38801 | — |
| Central Care Cancer Center | Bolivar | Missouri | 65613 | — |
| Phelps County Regional Medical Center | Rolla | Missouri | 65401 | — |
| Mercy Medical | Springfield | Missouri | 65804 | — |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | — |
| Essex Oncology | Belleville | New Jersey | 07109 | — |
| New York Oncology Group | Albany | New York | 12206 | — |
| Clinical Research Associates | Lake Success | New York | 11042 | — |
| NYU Laura & Isaac Perlmutter Cancer Center | New York | New York | 10016 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27517 | — |
| Southeastern Medical Oncology | Goldsboro | North Carolina | 27534 | — |
| Leo W. Jenkins Cancer Center - East Carolina University | Greenville | North Carolina | 27834 | — |
| Hematology and Oncology Associates - Mercy Medical Center | Canton | Ohio | 44708 | — |
| Tri-County Hematology & Oncology Associates | Massillon | Ohio | 44646 | — |
| Oregon Oncology Specialists (QCCA) | Salem | Oregon | 97301 | — |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | — |
| Bon Secours St. Francis Cancer Center | Greenville | South Carolina | 29607 | — |
| Arlington Cancer Center | Arlington | Texas | 76012 | — |
| JPS Health Network, JPS Center for Cancer Care | Fort Worth | Texas | 76104 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Scott & White Memorial Hospital and Clinic | Temple | Texas | 76508 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | — |
| Peace Health | Bellingham | Washington | 982256 | — |
| Northwest Medical Specialties, PLLC | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03289780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03289780 live on ClinicalTrials.gov.